<Suppliers Price>

Bapotulimab

Names

[ CAS No. ]:
2359413-58-2

[ Name ]:
Bapotulimab

Biological Activity

[Description]:

Bapotulimab (BAY-1905254) is a fully human IgG2 antibody targeting immunoglobulin-like domain containing receptor 2 (ILDR2). Bapotulimab has antitumor and immunosuppressive effects[1].

[Related Catalog]:

Research Areas >> Cancer
Signaling Pathways >> Others >> Others
Research Areas >> Inflammation/Immunology

[In Vitro]

Bapotulimab 阻断 ILDR2 对 T 细胞活化的免疫抑制作用。Bapotulimab 具有小鼠/人交叉反应性，因为 ILDR2 在人和鼠直系同源物的细胞外结构域之间具有 98% 的序列同一性[1]。 Bapotulimab (BAY-1905254；5、25、100 或 500 ng/mL) 在体外促进 T 细胞活化并增强抗原特异性 T 细胞增殖[1]。

[In Vivo]

Bapotulimab（BAY-1905254；10 mg/kg；腹腔注射；在第 1 天和第 4 天）显示抗原特异性 T 细胞增殖和细胞毒性显着增加[1]。 Animal Model: 8- to 12-week-old CD45.1-expressing C57BL/6 wild-type mice injected with OT-I transgenic T cells[1] Dosage: 10 mg/kg Administration: i.p.; on days 1 and 4 Result: Showed significantly increased antigen-specific T-cell proliferation and cytotoxicity.

[References]

[1]. Julia Huetter, et al. Characterization of BAY 1905254, an Immune Checkpoint Inhibitor Targeting the Immunoglobulin-Like Domain Containing Receptor 2 (ILDR2). Cancer Immunol Res. 2020 Jul;8(7):895-911.  

Chemical & Physical Properties

No Any Chemical & Physical Properties

Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.